Its downregulation seems to promote inhibition of cell proliferation and sensitization of cells to apoptosis induced by chemotherapeutic agents in prostate cancer [98], while silencing of Sam68 in breast cancer cells inhibits cancer proliferation. Here, KHDRBS1 is linked to breast carcinoma.